Mereo BioPharma Group plc
Nasdaq · Healthcare · Pharmaceutical Preparations · London
MREO chart
What traders are saying about $MREO
Latest postsMereo BioPharma Group plc news
- Mereo BioPharma Group plc Estimates – NASDAQ:MREO
TradingView ·
- Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights
Yahoo Finance ·
- Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
Yahoo Finance ·
- Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
Yahoo Finance ·
- European Equities Traded in the US as American Depositary Receipts Surge in Monday Trading
Yahoo Finance ·
- European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
Yahoo Finance ·
- Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates
Yahoo Finance ·
- We're Hopeful That Mereo BioPharma Group (NASDAQ:MREO) Will Use Its Cash Wisely
Yahoo Finance ·
- European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
Yahoo Finance ·
- European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading
Yahoo Finance ·
- European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading
Yahoo Finance ·
- European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading
Yahoo Finance ·
Mereo BioPharma Group plc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $500,000 | $0 | $10.0M | $0 |
| Net income | $41.9M | $43.3M | $29.5M | -$42.2M |
| Diluted EPS | $-0.05 | $-0.06 | $-0.04 | $-0.07 |
| Total assets (year end) | $45.9M | $76.4M | $66.5M | $77.4M |
| Cash and equivalents (year end) | $41.0M | $69.8M | $57.4M | $68.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Mereo BioPharma Group plc
- Ticker
- MREO (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- London
- Incorporated in
- United Kingdom
- Fiscal year end
- December 31
- SEC CIK
- 1719714
Frequently asked questions
What exchange is Mereo BioPharma Group plc listed on?
Mereo BioPharma Group plc trades on the Nasdaq under the ticker symbol MREO.
What industry is Mereo BioPharma Group plc in?
Mereo BioPharma Group plc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Mereo BioPharma Group plc headquartered?
Mereo BioPharma Group plc's business address on file with the SEC is in London.
When does Mereo BioPharma Group plc's fiscal year end?
Mereo BioPharma Group plc's fiscal year ends on December 31.
How much revenue did Mereo BioPharma Group plc report?
Mereo BioPharma Group plc reported $500,000 in revenue for calendar year 2025, according to its SEC filings.